| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Biomarker-based dissection of neurodegenerative diseases
|
Olsson, Bob
|
|
2011
|
95 |
4 |
p. 520-534
15 p.
|
artikel
|
| 2 |
Biomarkers and evolution in Alzheimer disease
|
Rapoport, Stanley I.
|
|
2011
|
95 |
4 |
p. 510-513
4 p.
|
artikel
|
| 3 |
Biomarkers for Alzheimer's disease therapeutic trials
|
Hampel, Harald
|
|
2011
|
95 |
4 |
p. 579-593
15 p.
|
artikel
|
| 4 |
Biomarkers for major depression and its delineation from neurodegenerative disorders
|
Schneider, Barbara
|
|
2011
|
95 |
4 |
p. 703-717
15 p.
|
artikel
|
| 5 |
Biomarkers in clinical trials for neurodegenerative diseases: Regulatory perspectives and requirements
|
Broich, Karl
|
|
2011
|
95 |
4 |
p. 498-500
3 p.
|
artikel
|
| 6 |
Biomarkers in frontotemporal lobar degenerations—Progress and challenges
|
Hu, William T.
|
|
2011
|
95 |
4 |
p. 636-648
13 p.
|
artikel
|
| 7 |
Biomarkers of Parkinson's disease and Dementia with Lewy bodies
|
Henchcliffe, Claire
|
|
2011
|
95 |
4 |
p. 601-613
13 p.
|
artikel
|
| 8 |
Development of Alzheimer-disease neuroimaging-biomarkers using mouse models with amyloid-precursor protein-transgene expression
|
Teipel, Stefan J.
|
|
2011
|
95 |
4 |
p. 547-556
10 p.
|
artikel
|
| 9 |
Development of biomarkers for multiple sclerosis as a neurodegenerative disorder
|
Ziemann, Ulf
|
|
2011
|
95 |
4 |
p. 670-685
16 p.
|
artikel
|
| 10 |
Discovery and development of integrative biological markers for schizophrenia
|
Oertel-Knöchel, Viola
|
|
2011
|
95 |
4 |
p. 686-702
17 p.
|
artikel
|
| 11 |
Editorial Board
|
|
|
2011
|
95 |
4 |
p. CO2-
1 p.
|
artikel
|
| 12 |
Ethical considerations of biomarker use in neurodegenerative diseases—A case study of Alzheimer's disease
|
Prvulovic, David
|
|
2011
|
95 |
4 |
p. 517-519
3 p.
|
artikel
|
| 13 |
Functional biomarkers for neurodegenerative disorders based on the network paradigm
|
Horwitz, Barry
|
|
2011
|
95 |
4 |
p. 505-509
5 p.
|
artikel
|
| 14 |
Functional magnetic resonance imaging as a dynamic candidate biomarker for Alzheimer's disease
|
Prvulovic, David
|
|
2011
|
95 |
4 |
p. 557-569
13 p.
|
artikel
|
| 15 |
Imaging biomarkers in Parkinson's disease
|
Brooks, David J.
|
|
2011
|
95 |
4 |
p. 614-628
15 p.
|
artikel
|
| 16 |
Neurodegenerative disease biomarkers: Guideposts for disease prevention through early diagnosis and intervention
|
Trojanowski, John Q.
|
|
2011
|
95 |
4 |
p. 491-495
5 p.
|
artikel
|
| 17 |
Neuroimaging and the question of neurodegeneration in schizophrenia
|
Meyer-Lindenberg, Andreas
|
|
2011
|
95 |
4 |
p. 514-516
3 p.
|
artikel
|
| 18 |
On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia
|
Geser, F.
|
|
2011
|
95 |
4 |
p. 649-662
14 p.
|
artikel
|
| 19 |
Perspectives of worldwide translational biomarker research in neurodegenerative diseases
|
Nicotera, Pierluigi
|
|
2011
|
95 |
4 |
p. 496-497
2 p.
|
artikel
|
| 20 |
Prevention trials in Alzheimer's disease: An EU-US task force report
|
Vellas, Bruno
|
|
2011
|
95 |
4 |
p. 594-600
7 p.
|
artikel
|
| 21 |
Recent developments of functional magnetic resonance imaging research for drug development in Alzheimer's disease
|
Hampel, Harald
|
|
2011
|
95 |
4 |
p. 570-578
9 p.
|
artikel
|
| 22 |
Staging Alzheimer's disease progression with multimodality neuroimaging
|
Ewers, Michael
|
|
2011
|
95 |
4 |
p. 535-546
12 p.
|
artikel
|
| 23 |
The ALS/PDC syndrome of Guam: Potential biomarkers for an enigmatic disorder
|
McGeer, Patrick L.
|
|
2011
|
95 |
4 |
p. 663-669
7 p.
|
artikel
|
| 24 |
The future of Alzheimer's disease: The next 10 years
|
Hampel, Harald
|
|
2011
|
95 |
4 |
p. 718-728
11 p.
|
artikel
|
| 25 |
The Parkinson Progression Marker Initiative (PPMI)
|
Marek, Kenneth
|
|
2011
|
95 |
4 |
p. 629-635
7 p.
|
artikel
|
| 26 |
The role of genetics for biomarker development in neurodegeneration
|
Bertram, Lars
|
|
2011
|
95 |
4 |
p. 501-504
4 p.
|
artikel
|
Tijdschrift beschrijving